Radiofrequency ablation of breast tumors along with the intralesional administration of IL-7 and IL-15 induce anti-tumor immune responses and inhibit tumor relapse and metastasis

被引：0
|
作者：
Habibi, M. [1 ]
Manjili, M. [2 ]
Bear, H. D. [2 ]
Keeler, J. M. [2 ]
Kmieciak, M. [2 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 27 条
  • [1] Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
    Mehran Habibi
    Maciej Kmieciak
    Laura Graham
    Johanna K. Morales
    Harry D. Bear
    Masoud H. Manjili
    Breast Cancer Research and Treatment, 2009, 114
  • [2] Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
    Habibi, Mehran
    Kmieciak, Maciej
    Graham, Laura
    Morales, Johanna K.
    Bear, Harry D.
    Manjili, Masoud H.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 423 - 431
  • [3] Upregulating IL-15 in the tumor microenvironment promotes anti-tumor responses
    Carrero, Rosa Maria Santana
    Beceren-Braun, Figen
    Rivas, Sarai C.
    Anthony, Scott M.
    Schluns, Kimberly S.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [4] IFN-γ-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice
    Comes, A
    Di Carlo, E
    Musiani, P
    Rosso, O
    Meazza, R
    Chiodoni, C
    Colombo, MP
    Ferrini, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (07) : 1914 - 1923
  • [5] Heterodimeric IL-15 regulates the balance of effector and regulatory cells, favoring anti-tumor responses
    Bergamaschi, Cristina
    Chen, Stephanie
    Valentin, Antonio
    Kulkarni, Viraj
    Bear, Jenifer
    Rosati, Margherita
    Alicea, Candido
    Beach, Rachel Kelly
    Sowder, Raymond
    Chertova, Elena
    Felber, Barbara K.
    Pavlakis, George N.
    CYTOKINE, 2013, 63 (03) : 247 - 248
  • [6] Effect of IL-15 on anti-tumor immune response to radio-immunotherapy through systemic immune activation
    Jin, Peng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes anti-tumor immune response
    Liu, Haiyan
    Zhao, Lixiang
    Mei, Yu
    Sun, Qing
    Guo, Linghua
    Liu, Xiufan
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [8] QL415, a tumor targeted IL-15 fusion protein stimulating both lymphoid and myeloid immune cells for optimal anti-tumor immune response
    Tang, Irene
    Schwimmer, Lauren
    Jin, Monica
    Gu, Shenda
    Prior, Wei Wei
    Capacio, Arianne
    Tran, Hieu V.
    Chan, Allan
    McClain, Anna
    Chen, Shihao
    Cao, Chuanzeng
    Wu, Xiaoran
    Xu, Yanling
    Guan, Dongmei
    Chen, Xi
    Su, Xianli
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Use of RLI-15 a clinical grade fusion protein with IL-15 superagonistic activity for the activation of anti-tumor immune response
    Adkins, Irena
    Sadilkova, Lenka
    Hradilova, Nada
    Tomala, Jakub
    Tomalova, Barbora
    Kovar, Marek
    Mikyskova, Romana
    Reinis, Milan
    de Martynoff, Guy
    Bechard, David
    Moebius, Ulrich
    Spisek, Radek
    CANCER RESEARCH, 2018, 78 (13)
  • [10] IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
    Wege, A. K.
    Weber, F.
    Ortmann, O.
    Nimmerjahn, F.
    Brockhoff, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 176 - 176
123